Search for: "AstraZeneca AB"
Results 81 - 92
of 92
Sort by Relevance
|
Sort by Date
3 Oct 2009, 9:05 pm
" Astrazeneca AB v. [read post]
3 Oct 2009, 12:10 am
" Astrazeneca AB v. [read post]
16 Aug 2009, 9:58 pm
Breath Ltd. 1:09-cv-04115; filed August 12, 2009 in the District Court of New Jersey • Plaintiffs: Astrazeneca LP; Astrazeneca AB • Defendant: Breath Ltd. [read post]
12 Mar 2009, 1:15 am
Astrazeneca AB v. [read post]
13 Jan 2009, 8:41 am
AstraZeneca AB: This case involves a burden of proof. [read post]
12 Jun 2008, 4:45 am
Omeprazole is the active ingredient in Prilosec ®, which is marketed by Plaintiffs-Appellants Astrazeneca, AB, Aktiebolaget Hassle, KBI-E, Inc., KBI, Inc., and Astrazeneca LP (Astrazeneca) for the treatment of gastric and duodenal ulcers, and which acts by inhibiting the production of gastric acid. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey shows most Americans… [read post]
20 Jan 2008, 6:55 pm
AstraZeneca AB et al. v. [read post]
14 Oct 2007, 6:39 pm
Pharmaceutical company AstraZeneca PLC, whose predecessor company, Astra AB, started off in China in 2000 with a manufacturing plant and a sales operation, has expanded its clinical-trials program here, added research staff and opened a purchasing operation. [read post]
25 Jul 2007, 3:15 pm
AstraZeneca sued after Andrx filed an Abbreviated New Drug Applications (ANDA) seeking FDA approval to market generic versions of Toprol-XL ®, which Astra claimed infringed its patents pursuant to 35 U.S.C. [read post]
23 Jul 2007, 4:04 pm
(AstraZeneca AB v. [read post]
